Search

Your search keyword '"Fotopoulou, Christina"' showing total 75 results

Search Constraints

Start Over You searched for: Author "Fotopoulou, Christina" Remove constraint Author: "Fotopoulou, Christina" Topic ovarian cancer Remove constraint Topic: ovarian cancer
75 results on '"Fotopoulou, Christina"'

Search Results

4. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

8. Analysis of Anxiety, Depression and Fear of Progression at 12 Months Post-Cytoreductive Surgery in the SOCQER-2 (Surgery in Ovarian Cancer—Quality of Life Evaluation Research) Prospective, International, Multicentre Study.

9. The role of neoadjuvant chemotherapy in advanced ovarian cancer: The right treatment to the right patient – Ensuring optimal outcomes in advanced ovarian cancer.

12. Investigating the Impact of Ultra-Radical Surgery on Survival in Advanced Ovarian Cancer Using Population-Based Data in a Multicentre UK Study.

13. Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER‐2 cohort study.

15. Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research.

17. British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom.

18. Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre study

19. Inflammatory state of lymphatic vessels and miRNA profiles associated with relapse in ovarian cancer patients.

21. TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO‐OVAR OP7).

22. Diagnostic value of post-operative platelet-to-white blood cell ratio after splenectomy in patients with advanced ovarian cancer.

23. What is the evidence for lymphadenectomy in presumed early ovarian cancer?

24. The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.

25. Aktuelle Aspekte der operativen Therapie des epithelialen Ovarialkarzinoms

26. European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery.

27. The passive biomechanics of human pelvic collecting lymphatic vessels.

28. Taking Responsibility: Ovarian Cancer Patients' Perspectives on Delayed Healthcare Seeking.

29. Incidence of Lymph Node Metastases in Apparent Early-Stage Low-Grade Epithelial Ovarian Cancer: A Comprehensive Review.

30. European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery.

32. The next steps in improving the outcomes of advanced ovarian cancer.

33. Quality of life and sexual function in patients with borderline tumors of the ovary. A substudy of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) study group ROBOT study.

34. Salvage Surgery Due To Bowel Obstruction in Advanced or Relapsed Ovarian Cancer Resulting in Short Bowel Syndrome and Long-Life Total Parenteral Nutrition.

35. Expression of Epithelial Cell Adhesion Molecule in Paired Tumor Samples of Patients With Primary and Recurrent Serous Ovarian Cancer.

36. The Molecular Fingerprint of High Grade Serous Ovarian Cancer Reflects Its Fallopian Tube Origin.

37. Primary Versus Interval Debulking Surgery in Advanced Ovarian Cancer.

38. Primary Radical Surgery in Elderly Patients With Epithelial Ovarian Cancer.

39. British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024.

40. Changes in Stem Cell Regulation and Epithelial Organisation during Carcinogenesis and Disease Progression in Gynaecological Malignancies.

41. Impact of postoperative residual disease on survival in epithelial ovarian cancer with consideration of recent frontline treatment advances: A systematic review and meta-analysis.

43. European Enhanced Recovery After Surgery (ERAS) gynecologic oncology survey: Status of ERAS protocol implementation across Europe.

44. Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancer: A meta-analysis.

45. OVA-LEAK: Prognostic score for colo-rectal anastomotic leakage in patients undergoing ovarian cancer surgery.

46. Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancer.

47. Impact of right upper quadrant cytoreductive techniques with extensive liver mobilization on postoperative hepatic function and risk of liver failure in patients with advanced ovarian cancer.

48. Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma.

49. Symptomization and triggering processes: Ovarian cancer patients' narratives on pre-diagnostic sensation experiences and the initiation of healthcare seeking.

50. A multicenter prospective external validation of the diagnostic performance of IOTA simple descriptors and rules to characterize ovarian masses.

Catalog

Books, media, physical & digital resources